Amir Shahram Yousefi Kashi
Overview
Explore the profile of Amir Shahram Yousefi Kashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faghihi Moghaddam F, Bakhshandeh M, Mofid B, Sahinbas H, Faeghi F, Mirzaei H, et al.
J Therm Biol
. 2024 Mar;
120:103804.
PMID: 38460451
Purpose: To evaluate the response rate, pain relief duration, and time it took for pain to decline or resolve after radiation therapy (RT) with or without fever-range Whole Body Hyperthermia...
2.
Fadavi P, Houshyari M, Yousefi Kashi A, Mosavi Jarrahi A, Roshanmehr F, Broomand M, et al.
Asian Pac J Cancer Prev
. 2021 Jan;
22(1):19-24.
PMID: 33507674
As of late 2019, the outbreak of novel coronavirus disease (COVID-19) -that started in China- has rapidly afflicted all over the world. The COVID-19 pandemic has challenged health-care facilities to...
3.
Ameri A, Rahnama N, Bozorgmehr R, Mokhtari M, Farahbakhsh M, Nabavi M, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jul;
108(5):1134-1139.
PMID: 32707264
Purpose: The COVID-19 outbreak is affecting people worldwide. Many infected patients have respiratory involvement that may progress to acute respiratory distress syndrome. This pilot study aimed to evaluate the clinical...
4.
5.
Mofid B, Razzaghdoust A, Yousefi Kashi A, Mirzaei H
Electron Physician
. 2016 Dec;
8(10):3069-3075.
PMID: 27957305
Introduction: Esophageal cancer is the seventh most frequent malignancy in Iranian men and the fourth most common cancer in Iranian women. It is also among the 10 most frequent cancers...
6.
Yousefi Kashi A, Khaledi S, Houshyari M
Iran J Cancer Prev
. 2016 Oct;
9(3):e6233.
PMID: 27703649
Background: Radiotherapy is the gold standard for treatment of prostrate cancer as it can cover an adequate area of tissues at risk for metastasis. Objectives: We evaluated the Pelvic lymph...
7.
Mofid B, Rezaeizadeh H, Termos A, Rakhsha A, Mafi A, Taheripanah T, et al.
Electron Physician
. 2016 Aug;
8(6):2475-82.
PMID: 27504161
Background: Cancer-related fatigue (CRF) is experienced by 50% to 90% of cancer patients and can severely affect their quality of life and functional capacity. Several randomized trials have recommended various...
8.
Rakhsha A, Yousefi Kashi A, Mofid B, Houshyari M
Electron Physician
. 2015 Oct;
7(6):1330-5.
PMID: 26516438
Introduction: Prostate cancer is now the third most frequent noncutaneous malignancy in Iranian men and the fifth most common cancer worldwide. Measurement of total serum prostate specific antigens (PSAs) has...
9.
Rakhsha A, Yousefi Kashi A, Hoseini S
Iran J Cancer Prev
. 2015 Oct;
8(4):e3573.
PMID: 26478798
Background: Cervical cancer remains to be a major health problem and cancer-related cause of death among women in developing countries such as Iran where the most cases are diagnosed in...
10.
Mofid B, Rezaeizadeh H, Jaladat A, Atarzadeh F, Moeini R, Motevalian A, et al.
Electron Physician
. 2015 Oct;
7(5):1220-6.
PMID: 26435820
Background: For patients receiving external beam radiation therapy (EBRT) after radical prostatectomy as adjuvant treatment or patients receiving EBRT as definitive treatment, partial irradiation of the urinary bladder is common....